Nodular regenerative hyperplasia: azathioprine-induced hepatotoxicity in a patient with Crohn's disease;Hiperplasia nodular regenerativa: hepatotoxicidad por azatioprina en un paciente con enfermedad de Crohn

Gastroenterologia y Hepatologia

Volumn 34, Issue 1, 2011, Pages 16-19

  López Martín, Cristina ^a   de la Fuente Fernández, Enrique ^a   Corbatón, Paloma ^a   Sánchez, María Chaparro ^a   Gisbert, J P ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Azathioprine; Crohn's disease; Hepatotoxicity; Nodular regenerative hyperplasia; Portal hypertension

Indexed keywords

AZATHIOPRINE;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; DRUG WITHDRAWAL; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER HYPERPLASIA; MALE; NODULAR HYPERPLASIA; NODULAR REGENERATIVE HYPERPLASIA; TREATMENT OUTCOME; ULTRASOUND;

AZATHIOPRINE; CROHN DISEASE; DRUG-INDUCED LIVER INJURY; HUMANS; HYPERPLASIA; HYPERTENSION, PORTAL; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; MIDDLE AGED;

EID: 79551485681     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.10.004     Document Type: Article

References (15)

1. Lichtenstein G.R., Abreu M.T., Cohen R., Tremaine W. American Gastroenterological Association Institute technical review on corticosteroids, inmunomodulators, and infliximab in inflamatory bowel disease. Gastroenterology. 2006, 130:940-987.
2. Gisbert J.P., González-Lama Y., Maté J. Thiopurine-induced liver injury in patients with inflamatory bowel disease: a sistematyc review. Am J Gastroenterol. 2007, 102:1518-1527.
3. Shaye O.A., Yadegari M., Abreu M.T., Poordad F., Simon K., Martin, et al. Hepatotoxicity of 6-mercaptopurine (6-MP) and azathioprine (AZA) in adult IBD patients. Am J Gastroenterol. 2007, 102:2488-2494.
4. Gisbert J.P., Luna M., González-Lama Y., Pousa I.D., Velasco M., Moreno-Otero R., et al. Liver injury in inflamatory bowel disease: long- term follow-up study of 786 patients. Inflamm Bowel Dis. 2007, 13:1106-1114.
5. Arnott I.D., Ghosh S. Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury. Eur J Gastroenterol Hepatol. 2000, 12:569-573.
6. Naer A.H., Van Haelst U., Yap S.H. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol. 1991, 12:94-99.
7. Dubinsky M.C., Vasiliauskas E.A., Singh H., Abreu M.T., Papadakis K.A., Tran T., et al. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology. 2003, 125:298-303.
8. Russmann S., Zimmermann A., Krähenbühl S., Kern B., Reichen J. Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol. 2001, 13:287-290.
9. Ferlitsch A., Telm A., Reinisch W., Ulbrich G., Wrba F., Homoncik M., et al. 6-Thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension. Am J Gastroenterol. 2007, 102:2485-2503.
10. Vernier-Massouille G., Cosnes J., Lemann M., Marteau P., Reinisch W., Laharie D., et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut. 2007, 56:1404-1409.
11. Mion F., Napoleon B., Berger F., Chevallier M., Bonvoisin S., Descos L. Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis. Gut. 1991, 32:715-717.
12. Seiderer J., Zech C.J., Walter R., Lukas M., Diebold J., Wrba F., et al. A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine. J Hepatol. 2005, 43:303-309.
13. Rulyak S.J., Saunders M.D., Lee S.D. Hepatotoxicity associated with 6-thioguanine therapy for Crohn's disease. J Clin Gastroenterol. 2003, 36:234-237.
14. Teml A., Schwab M., Harrer M., et al. A prospective, openlabel trial of 6-thioguanine in patients with ulcerative or indeterminate colitis. Scand J Gastroenterol. 2005, 40:1205-1213.
15. Herrlinger K.R., Deibert P., Schwab M., et al. Remission maintenance by tioguanine in chronic active Crohn's disease. Aliment Pharmacol Ther. 2003, 17:1459-1564.